Evaluation of ALA-PDT of ovarian cancer in the Fisher 344 rat tumor model

Photodiagnosis and Photodynamic Therapy

Volumn 4, Issue 4, 2007, Pages 254-260

  Ascencio, Manuel ^a   Delemer, Marie ^a   Farine, M O ^a   Jouve, Eva ^a   Collinet, Pierre ^a   Mordon, Serge ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

5 Aminolevulinic acid; 532 nm Laser; 630 nm Laser; Ovarian cancer; Photodynamic therapy; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; LASER; MESOTHELIUM; NONHUMAN; OVARY CANCER; PERITONEUM METASTASIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR VOLUME;

ANIMALIA; RATTUS;

EID: 36348990146     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2007.07.003     Document Type: Article

References (39)

1. Benedet J.L., Bender H., Jones III H., Ngan H.Y., and Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70 2 (2000) 209-262
2. Remontet L., Estève J., Bouvier A.M., et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Santé Publique 51 (2003) 3-30
3. Eisenkop S.M., Nalick R.H., Wang H.J., and Teng N.N. Peritoneal implant elimination during cytoreductive surgery for ovarian cancer: impact on survival. Gynecol Oncol 51 2 (1993) 224-229
4. McCarron P.A., Donnelly R.F., Zawislak A., Woolfson A.D., Price J.H., and McClelland R. Evaluation of a water-soluble bioadhesive patch for photodynamic therapy of vulval lesions. Int J Pharm 293 1-2 (2005) 11-23
5. McCarron P.A., Ma L.W., Juzenas P., et al. Facilitated delivery of ALA to inaccessible regions via bioadhesive patch systems. J Environ Pathol Toxicol Oncol 25 1-2 (2006) 389-402
6. Hillemanns P., Wang X., Staehle S., Michels W., and Dannecker C. Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy. Gynecol Oncol 100 2 (2006) 271-275
7. Saah-Briffaut E., Collinet P., Saah R., Boman F., and Leroy J.L. [Treatment of squamous intraepithelial lesion of type CIN2 et CIN3 with laser CO2 vaporization: retrospective study of 52 cases]. J Gynecol Obstet Biol Reprod (Paris) 35 8 Pt 1 (2006) 785-789
8. Yamaguchi S., Tsuda H., Takemori M., et al. Photodynamic therapy for cervical intraepithelial neoplasia. Oncology 69 2 (2005) 110-116
9. Zaak D., Sroka R., Stocker S., et al. Photodynamic therapy of prostate cancer by means of 5-aminolevulinic acid-induced protoporphyrin IX - in vivo experiments on the dunning rat tumor model. Urol Int 72 3 (2004) 196-202
10. El Khatib S., Didelon J., Leroux A., Bezdetnaya L., Notter D., and D'Hallewin M. Kinetics, biodistribution and therapeutic efficacy of hexylester 5-aminolevulinate induced photodynamic therapy in an orthotopic rat bladder tumor model. J Urol 172 5 Pt 1 (2004) 2013-2017
11. Gossner L., Sroka R., Hahn E.G., and Ell C. Photodynamic therapy: successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid. Gastrointest Endosc 41 1 (1995) 55-58
12. Pech O., Gossner L., May A., et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc 62 1 (2005) 24-30
13. Regula J., Ravi B., Bedwell J., MacRobert A.J., and Bown S.G. Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer-prolonged animal survival. Br J Cancer 70 2 (1994) 248-254
14. Ziolkowski P., Osiecka B.J., Oremek G., et al. Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture. J Exp Ther Oncol 4 2 (2004) 121-129
15. Fijan S., Honigsmann H., and Ortel B. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine. Br J Dermatol 133 2 (1995) 282-288
16. Betz C.S., Lai J.P., Xiang W., et al. In vitro photodynamic therapy of nasopharyngeal carcinoma using 5-aminolevulinic acid. Photochem Photobiol Sci 1 5 (2002) 315-319
17. Henderson B.W., and Dougherty T.J. How does photodynamic therapy work?. Photochem Photobiol 55 1 (1992) 145-157
18. Kennedy J.C., and Pottier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 14 4 (1992) 275-292
19. Loning M.C., Diddens H.C., Holl-Ulrich K., et al. Fluorescence staining of human ovarian cancer tissue following application of 5-aminolevulinic acid: Fluorescence microscopy studies. Lasers Surg Med (2006)
20. Haddad R., Kaplan O., Greenberg R., Siegal A., Skornick Y., and Kashtan H. Photodynamic therapy of murine colon cancer and melanoma using systemic aminolevulinic acid as a photosensitizer. Int J Surg Investig 2 3 (2000) 171-178
21. Buchczyk D.P., Klotz L.O., Lang K., Fritsch C., and Sies H. High efficiency of 5-aminolevulinate-photodynamic treatment using UVA irradiation. Carcinogenesis 22 6 (2001) 879-883
22. Boere I.A., Robinson D.J., de Bruijn H.S., van den Boogert J., Tilanus H.W., and Sterenborg H.J. Monitoring in situ dosimetry and protoporphyrin IX fluorescence photobleaching in the normal rat esophagus during 5-aminolevulinic acid photodynamic therapy. Photochem Photobiol 78 3 (2003) 271-277
23. Rose G.S., Tocco L.M., Granger G.A., et al. Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. Am J Obstet Gynecol 175 3 Pt 1 (1996) 593-599
24. Hornung R., Fink D., Dobler-Girdziunaite D., Stallmach T., Haller U., and Walt H. Photodynamic therapy for the hypercalcemic type of the small cell carcinoma of the ovary in a mouse xenograft model. Gynecol Oncol 75 3 (1999) 447-452
25. Major A.L., Rose G.S., Svaasand L.O., Ludicke F., Campana A., and van Gemert M.J. Intraperitoneal photodynamic therapy in the Fischer 344 rat using 5-aminolevulinic acid and violet laser light: a toxicity study. J Photochem Photobiol B 66 2 (2002) 107-114
26. Hendren S.K., Hahn S.M., Spitz F.R., et al. Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Ann Surg Oncol 8 1 (2001) 65-71
27. Sporri S., Chopra V., Egger N., et al. Effects of 5-aminolaevulinic acid on human ovarian cancer cells and human vascular endothelial cells in vitro. J Photochem Photobiol B 64 1 (2001) 8-20
28. Shahzidi S., Stokke T., Soltani H., Nesland J.M., and Peng Q. Induction of apoptosis by hexaminolevulinate-mediated photodynamic therapy in human colon carcinoma cell line 320DM. J Environ Pathol Toxicol Oncol 25 1-2 (2006) 159-171
29. Furre I.E., Moller M.T., Shahzidi S., Nesland J.M., and Peng Q. Involvement of both caspase-dependent and -independent pathways in apoptotic induction by hexaminolevulinate-mediated photodynamic therapy in human lymphoma cells. Apoptosis 11 11 (2006) 2031-2042
30. Furre I.E., Shahzidi S., Luksiene Z., et al. Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells. Cancer Res 65 23 (2005) 11051-11060
31. Etienne J., Dorme N., Bourg-Heckly G., Raimbert P., and Flejou J.F. Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 59 7 (2004) 880-889
32. Grosjean P., Wagnieres G., Fontolliet C., van den Bergh H., and Monnier P. Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II. Br J Cancer 77 11 (1998) 1989-1995
33. Dougherty T.J. Photodynamic therapy (PDT) of malignant tumors. Crit Rev Oncol Hematol 2 2 (1984) 83-116
34. McCaughan Jr. J.S., Hicks W., Laufman L., May E., and Roach R. Palliation of esophageal malignancy with photoradiation therapy. Cancer 54 12 (1984) 2905-2910
35. Hornung R., Fehr M.K., Monti-Frayne J., et al. Highly selective targeting of ovarian cancer with the photosensitizer PEG-m-THPC in a rat model. Photochem Photobiol 70 4 (1999) 624-629
36. Hornung R., Fehr M.K., Monti-Frayne J., Tromberg B.J., Berns M.W., and Tadir Y. Minimally-invasive debulking of ovarian cancer in the rat pelvis by means of photodynamic therapy using the pegylated photosensitizer PEG-m-THPC. Br J Cancer 81 4 (1999) 631-637
37. Waidelich R., Beyer W., Knuchel R., et al. Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light source. Urology 61 2 (2003) 332-337
38. Mordon S., and Maunoury V. Using white light during photodynamic therapy: visualization only or treatment?. Eur J Gastroenterol Hepatol 18 7 (2006) 765-771
39. Collinet P., Sabban F., Cosson M., et al. Laparoscopic photodynamic diagnosis of ovarian cancer peritoneal micro metastasis: An experimental study. Photochem Photobiol 83 (2007) 647-651